A Pilot Study to Extend the K-SADS-PL to Adolescents and Young Adults
NCT01778478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2019-12-17
Summary
Background:
\- An interview called the Schedule for Affective Disorders and Schizophrenia for School Age Children Present and Lifetime version (K-SADS-PL) is used to identify mental health problems among children and younger teens. Both the child and a parent are asked questions about the child s behaviors and symptoms that might indicate such problems. Researchers want to see if the K-SADS-PL can help identify mental health problems in young adults (ages 18 to 25). Two groups of young adults, including healthy volunteers and people with cancer, and their parents will participate in this study.
Objectives:
* To see if the K-SADS-PL interview used for children and teens can also be used for young adults.
* To see whether information provided by parents will affect the rate of mental health problems found.
Eligibility:
* Individuals aged 18-25 years who have cancer and are participating in research studies at the National Institutes of Health.
* Healthy volunteers aged 18-25 years.
* A parent of a young adult who is participating in this study.
Design:
* This study requires one study visit that includes an interview and self-report questionnaires. It will take about 1 to 3 hours. A follow-up phone call or visit will also be required.
* Young adult participants will be given the K-SADS-PL interview and four questionnaires that ask about mood, anxiety, distress, parental contact, and development during childhood. The K-SADS-PL interview will be video recorded or audio recorded.
* Parents will also be given the K-SADS-PL interview. This interview can be done in person or by phone, and will also be recorded.
* No treatment will be provided as part of this study.
Conditions
- Depression
- Anxiety Disorder
- Cancer
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
lead NIH
Principal Investigators
-
Joyce Y Chung, M.D. · National Institute of Mental Health (NIMH)
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-26
- Primary Completion
- 2016-08-25
- Completion
- 2018-05-23
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Obsessive-Compulsive Disorder (OCD) in Children
NCT00000384 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD)
NCT00766064 ·Status: WITHDRAWN ·Phase: PHASE4
-
Child and Adolescent Anxiety Disorders (CAMS)
NCT00052078 ·Status: COMPLETED ·Phase: PHASE3
-
A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder
NCT00542685 ·Status: COMPLETED ·Phase: PHASE3
-
Personalized Digital Treatment for Adolescent Anxiety: A Feasibility Trial
NCT07145307 ·Status: RECRUITING ·Phase: NA
-
A Study in Pediatric Participants With Generalized Anxiety Disorder
NCT01226511 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia
NCT00576719 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder
NCT03924323 ·Status: COMPLETED ·Phase: PHASE4
-
A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
NCT00236015 ·Status: COMPLETED ·Phase: PHASE3
-
Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder
NCT00208741 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Mechanisms of Psychosocial Treatments for Panic Disorder
NCT04366011 ·Status: COMPLETED ·Phase: NA
-
Treatment for Specific Phobias in Children
NCT00051220 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacological Treatment of Generalized Anxiety Disorder in the Elderly
NCT00701675 ·Status: COMPLETED ·Phase: PHASE4
-
A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
NCT00236054 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of NTX-1472 in Social Anxiety Disorder
NCT07323784 ·Status: RECRUITING ·Phase: PHASE2
-
Does Increasing Attentional Control Decrease Acute Fear Response
NCT04080115 ·Status: COMPLETED ·Phase: NA
-
N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder
NCT01172275 ·Status: COMPLETED ·Phase: PHASE2
-
А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder
NCT04524975 ·Status: COMPLETED ·Phase: PHASE2
-
Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)
NCT05401565 ·Status: COMPLETED ·Phase: PHASE2
-
Prefrontal Oscillations in Social Anxiety Disorder (POSAD)
NCT03821779 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Treatment of Childhood Social Phobia
NCT00043537 ·Status: COMPLETED ·Phase: PHASE3
-
Using Personalized Assessments in the Treatment of Childhood OCD
NCT06407648 ·Status: RECRUITING ·Phase: NA
-
Quetiapine in Social Anxiety Disorder
NCT00215254 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Brief Shame Intervention Study
NCT03463356 ·Status: COMPLETED ·Phase: NA
-
Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment Study
NCT00774150 ·Status: COMPLETED ·Phase: NA